Drug Safety Research Unit (DSRU)

The Drug Safety Research Unit (DSRU) is a leading pharmacovigilance and pharmacoepidemiology unit based in United Kingdom. Established in 1981, DSRU is dedicated to upholding the highest scientific and ethical standards while prioritizing patient interests. The organization's strong ties with NHS doctors enable it to conduct primary and secondary care studies, particularly those related to risk management under EU Risk Management Plans (RMPs). DSRU's focus on pharmacovigilance involves detecting drug-related side effects and carrying out comprehensive safety evaluations. With a track record of producing publications in international peer-reviewed journals, the unit has garnered acclaim from regulatory authorities, healthcare professionals, and the pharmaceutical industry globally. Despite not having a recent documented investment, DSRU's contributions to the post-marketing surveillance of pharmaceutical products underscore its efficacy and impact within the Health Care and Pharmaceutical industries.